bigger, it is because you are. At Amgen, our shared mission to serve patients drives everything we do. It is what has made... & INFLAMMATORY DISEASE LIVE What you will do In this senior role, you will provide medical leadership across Amgen’s rare...
of something bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key... patients above all else, Amgen is the first to imagine, and the last to doubt. Join us. careers.amgen.com Equal Opportunity...
of something bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key... Organizations (CROs), ensuring high-quality, compliant, and efficient delivery in support of Amgen’s clinical trials...
bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key to our becoming.... APPLY NOW for a career that defies imagination In our quest to serve patients above all else, Amgen is the first to imagine, and the last...
bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key to our becoming... management and ensure compliance for global and local clinical trials by supporting study teams and trial sites involved in Amgen...
like you’re part of something bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives..., compliance controls and process improvements Be part of our team You will be joining a team that helps Amgen’s UK...
Career Category Regulatory Job Description Join Amgen’s Mission of Serving Patients At Amgen, if you feel... millions of patients each year. Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease...
Career Category Government Affairs Job Description The Corporate Affairs Manager at Amgen supports the development...’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key to our becoming one of the world’s leading...
delivery. As the study portfolio grows (DENI-04 now, Amgen activating October, and potentially Roche studies in early 2027...